Bincy Abraham, M.D. Download Headshot

Bincy Abraham, MD, MS

  • Houston Methodist gastroenterologist
  • Inflammatory bowel disease program director, Houston Methodist Hospital Lynda K. and David M. Underwood Center for Digestive Disorders
  • Fondren Distinguished Professor in Inflammatory Bowel Disease, Houston Methodist Hospital Department of Medicine
  • Associate Professor of Clinical Medicine, Houston Methodist Institute for Academic Medicine
Media Contact: Gale Smith , 832.667.5843

Bincy Abraham, MD, MS

Request Interview
Media Contact: Gale Smith , 832.667.5843

Areas of Expertise

  • Capsule endoscopy
  • Clinical Trials
  • Crohn's disease
  • Pregnancy & inflammatory bowel disease
  • Transition of care in inflammatory bowel disease
  • Ulcerative colitis

Credentials

RESIDENCY
University of Texas Medical Branch - Galveston, TX | 2005
INTERNSHIP
University of Texas Medical Branch - Galveston, TX | 2003
MEDICAL SCHOOL
University of Texas Medical Branch at Galveston | 2002
BOARD CERTIFICATION
Gastroenterology | American Board of Internal Medicine
FELLOWSHIP
Gastroenterology - University of Texas Medical Branch - Galveston, TX | 2008

Publications

AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary
Chavannes, M, Dolinger, MT, Cohen-Mekelburg, S & Abraham, B 2024, , Clinical Gastroenterology and Hepatology, vol. 22, no. 9, pp. 1790-1795.e1. https://doi.org/10.1016/j.cgh.2024.04.039

Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis
Ouranos, K, Saleem, H, Vassilopoulos, S, Vassilopoulos, A, Mylona, EK, Shehadeh, F, Kalligeros, M, Abraham, BP & Mylonakis, E 2024, , Inflammatory bowel diseases. https://doi.org/10.1093/ibd/izae031

Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab
Ansari, M, Glassner, K, Irani, M, Saleh, A, Wang, L, Ezeana, C, Wong, S, Perry, C & Abraham, B 2024, , Journal of Digestive Diseases, vol. 25, no. 2, pp. 91-99. https://doi.org/10.1111/1751-2980.13261

Role of the industry representative in the practice of gastroenterology and GI endoscopy
(ASGE ARIA Committee Chair) 2024, , Gastrointestinal Endoscopy, vol. 99, no. 3, pp. 307-313. https://doi.org/10.1016/j.gie.2023.10.057

Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab
Saleh, A, Stading, R, Miroballi, N, Glassner, K & Abraham, BP 2024, , Journal of Digestive Diseases, vol. 25, no. 4, pp. 214-221. https://doi.org/10.1111/1751-2980.13264

Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn’s Disease
Moskow, J, Thurston, T, Saleh, A, Shah, A, Abraham, BP & Glassner, K 2024, , Digestive Diseases and Sciences, vol. 69, no. 8, pp. 2944-2954. https://doi.org/10.1007/s10620-024-08471-0

WHAT IS THE ROLE OF PROBIOTICS FOR PATIENTS WITH IBD?
Glassner, K & Abraham, BP 2024, in Curbside Consultation in IBD: 49 Clinical Questions. CRC Press, pp. 143-147. https://doi.org/10.1201/9781003523567-28

Irritable Bowel Syndrome in Women With IBD
Abraham, BP, Glassner, KL & Quigley, EM 2024, . in Women’s Health in IBD: The Spectrum of Care From Birth to Adulthood. CRC Press, pp. 195-212.


Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication
Maconi, G, Lepore, F, Saleh, A, Saibeni, S, Bezzio, C, Cheli, S, Massari, A, Gridavilla, D, Ferretti, F, Cannatelli, R, Ardizzone, S, Clementi, E & Abraham, B 2024, , Digestive and Liver Disease, vol. 56, no. 12, pp. 2052-2059. https://doi.org/10.1016/j.dld.2024.05.026

Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date
Glassner, K, Fan, C, Irani, M & Abraham, BP 2024, , Clinical and Experimental Gastroenterology, vol. 17, pp. 337-345. https://doi.org/10.2147/CEG.S391706

Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine Series
Thomas, B, Moskow, J, Garza, M, Warren, B, Abraham, B & Glassner, K 2023, , ACG case reports journal, vol. 10, no. 12, pp. e01221. https://doi.org/10.14309/crj.0000000000001221


The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
Abraham, BP, Fan, C, Thurston, T, Moskow, J & Malaty, HM 2023, , Nutrients, vol. 15, no. 22, 4847. https://doi.org/10.3390/nu15224847

Real-World Impact of Infliximab Precision-Guided Dosing on Management of Patients With IBD
Abraham, BP, Ziring, DA, Dervieux, T, Han, PA, Shim, A & Battat, R 2023, , American Journal of Managed Care, vol. 29, no. 12 Suppl, pp. S227-S235. https://doi.org/10.37765/AJMC.2023.89447

The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis
Saleh, A, Parsa, S, Garza, M, Quigley, EMM & Abraham, BP 2023, , Digestive Diseases, vol. 41, no. 4, pp. 656-665. https://doi.org/10.1159/000529591

Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel Disease
Saleh, A & Abraham, BP 2023, , Crohns and Colitis 360, vol. 5, no. 3, otad027, pp. otad027. https://doi.org/10.1093/crocol/otad027

Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started
Abraham, BP, Reddy, D & Saleh, A 2023, , Crohns and Colitis 360, vol. 5, no. 3, otad043, pp. otad043. https://doi.org/10.1093/crocol/otad043

The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients
Liu, JJ, Abraham, BP, Adamson, P, Barnes, EL, Brister, KA, Damas, OM, Glover, SC, Hooks, K, Ingram, A, Kaplan, GG, Loftus, EV, McGovern, DPB, Narain-Blackwel, M, Odufalu, FD, Quezada, S, Reeves, V, Shen, B, Stappenbeck, TS & Ward, L 2023, , Inflammatory bowel diseases, vol. 29, no. 2, pp. 297-307. https://doi.org/10.1093/ibd/izac124

Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease
Papamichael, K, Vande Casteele, N, Abraham, BP, Ritter, T, Jain, A & Cheifetz, AS 2023, , Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2022.10.037

Languages

English